|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
DK0942000T3
(da)
*
|
1989-10-24 |
2004-11-01 |
Isis Pharmaceuticals Inc |
2'-modificerede oligonukleotider
|
|
US6005087A
(en)
*
|
1995-06-06 |
1999-12-21 |
Isis Pharmaceuticals, Inc. |
2'-modified oligonucleotides
|
|
US5412087A
(en)
|
1992-04-24 |
1995-05-02 |
Affymax Technologies N.V. |
Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
|
|
AU3728093A
(en)
|
1992-02-19 |
1993-09-13 |
Public Health Research Institute Of The City Of New York, Inc., The |
Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
|
|
US6309823B1
(en)
|
1993-10-26 |
2001-10-30 |
Affymetrix, Inc. |
Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
|
|
US20040203024A1
(en)
*
|
1996-06-06 |
2004-10-14 |
Baker Brenda F. |
Modified oligonucleotides for use in RNA interference
|
|
US5898031A
(en)
*
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US20040171031A1
(en)
*
|
1996-06-06 |
2004-09-02 |
Baker Brenda F. |
Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
US20040147022A1
(en)
*
|
1996-06-06 |
2004-07-29 |
Baker Brenda F. |
2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
|
|
WO1998012354A1
(en)
|
1996-09-19 |
1998-03-26 |
Affymetrix, Inc. |
Identification of molecular sequence signatures and methods involving the same
|
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
CA2303299C
(en)
|
1997-09-12 |
2016-02-23 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US7572582B2
(en)
|
1997-09-12 |
2009-08-11 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US6506559B1
(en)
*
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
US7045610B2
(en)
*
|
1998-04-03 |
2006-05-16 |
Epoch Biosciences, Inc. |
Modified oligonucleotides for mismatch discrimination
|
|
US6324479B1
(en)
|
1998-05-08 |
2001-11-27 |
Rosetta Impharmatics, Inc. |
Methods of determining protein activity levels using gene expression profiles
|
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
|
US6316193B1
(en)
|
1998-10-06 |
2001-11-13 |
Origene Technologies, Inc. |
Rapid-screen cDNA library panels
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
|
US6734291B2
(en)
|
1999-03-24 |
2004-05-11 |
Exiqon A/S |
Synthesis of [2.2.1]bicyclo nucleosides
|
|
DK1163250T3
(da)
|
1999-03-24 |
2006-11-13 |
Exiqon As |
Forbedret syntese af [2.2.1]bicyclonukleosider
|
|
NZ514348A
(en)
|
1999-05-04 |
2004-05-28 |
Exiqon As |
L-ribo-LNA analogues
|
|
US6083482A
(en)
|
1999-05-11 |
2000-07-04 |
Icn Pharmaceuticals, Inc. |
Conformationally locked nucleosides and oligonucleotides
|
|
WO2001025478A1
(en)
|
1999-10-04 |
2001-04-12 |
Exiqon A/S |
A method of increasing the specificity of oxy-lna oligonucleotides
|
|
US20050020525A1
(en)
*
|
2002-02-20 |
2005-01-27 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US20070026394A1
(en)
*
|
2000-02-11 |
2007-02-01 |
Lawrence Blatt |
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies
|
|
US8202979B2
(en)
*
|
2002-02-20 |
2012-06-19 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
|
|
ATE450621T2
(de)
*
|
2000-03-30 |
2009-12-15 |
Whitehead Biomedical Inst |
Mediatoren von rns-interferenz, die rns- sequenzspezifisch sind
|
|
EP1332150A1
(en)
|
2000-11-09 |
2003-08-06 |
Jyoti Chattopadhyaya |
Modified nucleosides and nucleotides and use thereof
|
|
KR100872437B1
(ko)
*
|
2000-12-01 |
2008-12-05 |
막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. |
Ｒｎａ 간섭을 매개하는 작은 ｒｎａ 분자
|
|
US20030077609A1
(en)
*
|
2001-03-25 |
2003-04-24 |
Jakobsen Mogens Havsteen |
Modified oligonucleotides and uses thereof
|
|
US20050148530A1
(en)
*
|
2002-02-20 |
2005-07-07 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
US20070042983A1
(en)
*
|
2001-05-18 |
2007-02-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
|
US7053195B1
(en)
*
|
2001-06-12 |
2006-05-30 |
Syngenta Participatious Ag |
Locked nucleic acid containing heteropolymers and related methods
|
|
GB0114719D0
(en)
*
|
2001-06-15 |
2001-08-08 |
Glaxo Group Ltd |
Compound
|
|
WO2003020739A2
(en)
|
2001-09-04 |
2003-03-13 |
Exiqon A/S |
Novel lna compositions and uses thereof
|
|
AU2003207708A1
(en)
|
2002-02-20 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of map kinase genes
|
|
SI2264172T1
(sl)
*
|
2002-04-05 |
2017-12-29 |
Roche Innovation Center Copenhagen A/S |
Oligomerne spojine za modulacijo izražanja HIF-1alfa
|
|
US7569575B2
(en)
*
|
2002-05-08 |
2009-08-04 |
Santaris Pharma A/S |
Synthesis of locked nucleic acid derivatives
|
|
JP4476802B2
(ja)
|
2002-05-08 |
2010-06-09 |
サンタリス ファーマ アー／エス |
ロックト核酸誘導体の製造
|
|
AU2003241621A1
(en)
*
|
2002-05-24 |
2003-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
|
US20050053942A1
(en)
|
2002-06-24 |
2005-03-10 |
Sakari Kauppinen |
Methods and systems for detection and isolation of a nucleotide sequence
|
|
US8101348B2
(en)
*
|
2002-07-10 |
2012-01-24 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. |
RNA-interference by single-stranded RNA molecules
|
|
EP1532248B1
(en)
*
|
2002-07-26 |
2009-04-01 |
Novartis Vaccines and Diagnostics, Inc. |
Modified small interfering rna molecules and methods of use
|
|
ES2280826T5
(es)
*
|
2002-08-05 |
2017-08-03 |
Silence Therapeutics Gmbh |
Nuevas formas adicionales de moléculas de ARN de interferencia
|
|
WO2004014933A1
(en)
*
|
2002-08-07 |
2004-02-19 |
University Of Massachusetts |
Compositions for rna interference and methods of use thereof
|
|
EP1556402B1
(en)
*
|
2002-09-25 |
2011-06-22 |
University of Massachusetts |
In vivo gene silencing by chemically modified and stable sirna
|
|
US7422853B1
(en)
*
|
2002-10-04 |
2008-09-09 |
Myriad Genetics, Inc. |
RNA interference using a universal target
|
|
US20040219565A1
(en)
*
|
2002-10-21 |
2004-11-04 |
Sakari Kauppinen |
Oligonucleotides useful for detecting and analyzing nucleic acids of interest
|
|
WO2004035819A2
(en)
|
2002-10-21 |
2004-04-29 |
Exiqon A/S |
Oligonucleotide analogues for detecting and analyzing nucleic acids
|
|
WO2004041889A2
(en)
*
|
2002-11-05 |
2004-05-21 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
JP2006507841A
(ja)
*
|
2002-11-14 |
2006-03-09 |
ダーマコン， インコーポレイテッド |
機能的ｓｉＲＮＡおよび超機能的ｓｉＲＮＡ
|
|
US9045518B2
(en)
*
|
2002-11-18 |
2015-06-02 |
Santaris Pharma A/S |
Amino-LNA, thio-LNA and alpha-L-oxy-LN
|
|
US20040248299A1
(en)
*
|
2002-12-27 |
2004-12-09 |
Sumedha Jayasena |
RNA interference
|
|
ES2356910T3
(es)
*
|
2003-01-17 |
2011-04-14 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Construcciones para la expresión inducible de arn de interferencia pequeño (arns) para el silenciamiento génico seleccionado.
|
|
US7713738B2
(en)
*
|
2003-02-10 |
2010-05-11 |
Enzon Pharmaceuticals, Inc. |
Oligomeric compounds for the modulation of survivin expression
|
|
US20040241717A1
(en)
*
|
2003-02-10 |
2004-12-02 |
Santaris Pharma A/S |
Oligomeric compounds for the modulation of thioredoxin expression
|
|
EP1592795A2
(en)
*
|
2003-02-10 |
2005-11-09 |
Santaris Pharma A/S |
Oligomeric compounds for the modulation of ras expression
|
|
WO2004080406A2
(en)
|
2003-03-07 |
2004-09-23 |
Alnylam Pharmaceuticals |
Therapeutic compositions
|
|
US8653252B2
(en)
*
|
2003-03-21 |
2014-02-18 |
Santaris Pharma A/S |
Short interfering RNA (siRNA) analogues
|
|
US20040198640A1
(en)
*
|
2003-04-02 |
2004-10-07 |
Dharmacon, Inc. |
Stabilized polynucleotides for use in RNA interference
|
|
JP4597976B2
(ja)
*
|
2003-04-17 |
2010-12-15 |
アルナイラム ファーマシューティカルズ インコーポレイテッド |
修飾ｉＲＮＡ剤
|
|
AU2004252442B2
(en)
*
|
2003-06-02 |
2010-04-08 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of FNAi
|
|
ES2712695T3
(es)
*
|
2003-06-02 |
2019-05-14 |
Univ Massachusetts |
Métodos y composiciones para controlar la eficacia de la silenciación del ARN
|
|
US7750144B2
(en)
*
|
2003-06-02 |
2010-07-06 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
|
|
WO2005014782A2
(en)
*
|
2003-06-13 |
2005-02-17 |
Alnylam Europe Ag., |
Double-stranded ribonucleic acid with increased effectiveness in an organism
|
|
US20060241072A1
(en)
*
|
2003-06-20 |
2006-10-26 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds for use in gene modulation
|
|
US20050256071A1
(en)
*
|
2003-07-15 |
2005-11-17 |
California Institute Of Technology |
Inhibitor nucleic acids
|
|
US20050136437A1
(en)
*
|
2003-08-25 |
2005-06-23 |
Nastech Pharmaceutical Company Inc. |
Nanoparticles for delivery of nucleic acids and stable double-stranded RNA
|
|
US20050053981A1
(en)
*
|
2003-09-09 |
2005-03-10 |
Swayze Eric E. |
Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
|
|
US20050086356A1
(en)
*
|
2003-10-15 |
2005-04-21 |
Shah Mehul Y. |
Systems and methods for scheduled recording of multimedia content streams
|
|
US20060134787A1
(en)
*
|
2004-12-22 |
2006-06-22 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
|
|
JP4642775B2
(ja)
*
|
2003-12-23 |
2011-03-02 |
サンタリス ファーマ アー／エス |
Ｂｃｌ−２のモデュレーションのためのオリゴマー化合物
|
|
US20080249039A1
(en)
*
|
2004-01-30 |
2008-10-09 |
Santaris Pharma A/S |
Modified Short Interfering Rna (Modified Sirna)
|
|
US8084599B2
(en)
*
|
2004-03-15 |
2011-12-27 |
City Of Hope |
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
|
|
KR101147147B1
(ko)
*
|
2004-04-01 |
2012-05-25 |
머크 샤프 앤드 돔 코포레이션 |
Ｒｎａ 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
|
|
US7575863B2
(en)
*
|
2004-05-28 |
2009-08-18 |
Applied Biosystems, Llc |
Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
|
|
US8394947B2
(en)
*
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
|
WO2006093526A2
(en)
*
|
2004-07-21 |
2006-09-08 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
|
EP1791982B1
(en)
*
|
2004-09-21 |
2011-01-05 |
Life Technologies Corporation |
TWO-COLOR REAL-TIME/END-POINT QUANTITATION OF MICRORNAS (MIRNAs)
|
|
CA2586701C
(en)
*
|
2004-11-09 |
2014-06-03 |
Santaris Pharma A/S |
Lna oligonucleotides and the treatment of cancer
|
|
MX2007005558A
(es)
*
|
2004-11-09 |
2008-01-31 |
Santaris Pharma As |
Oligonucleotidos de lna potentes para la inhibicion dela expresion de hif-1a.
|
|
US20070065840A1
(en)
*
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
|
US20060234277A1
(en)
*
|
2005-03-31 |
2006-10-19 |
Amgen Inc. |
Method for selectively blocking hemoglobin RNA amplification
|
|
ATE532878T1
(de)
*
|
2005-08-24 |
2011-11-15 |
Life Technologies Corp |
Verfahren zur quantifizierung von sirnas, mirnas und polymorphen mirnas
|
|
WO2007051303A1
(en)
*
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
|
DK1984382T3
(da)
*
|
2006-01-27 |
2012-09-03 |
Santaris Pharma As |
LNA modificerede fosforthiolerede oligonukleotider
|
|
CA2651453C
(en)
*
|
2006-05-11 |
2014-10-14 |
Isis Pharmaceuticals, Inc. |
5'-modified bicyclic nucleic acid analogs
|
|
WO2009002944A1
(en)
|
2007-06-22 |
2008-12-31 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
|
CN101849008A
(zh)
|
2007-09-19 |
2010-09-29 |
应用生物系统有限公司 |
用于减少RNAi中的脱靶表型效应的siRNA的不依赖于序列的修饰形式和其稳定形式
|
|
KR20100110298A
(ko)
*
|
2007-11-26 |
2010-10-12 |
산타리스 팔마 에이/에스 |
안드로겐 수용체를 표적화하는 ｌｎａ 길항제
|
|
KR100949791B1
(ko)
|
2007-12-18 |
2010-03-30 |
이동기 |
오프-타겟 효과를 최소화하고 ＲＮＡｉ 기구를 포화시키지않는 신규한 ｓｉＲＮＡ 구조 및 그 용도
|